CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
6 hedge funds and large institutions have $5.46M invested in Celyad Oncology SA American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$10.3K |
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$285K |
| 2 |
Morgan Stanley
New York
|
-$45.7K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$13.8K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Victory Capital Management
San Antonio,
Texas
| $5.23M | -$285K | -40,890 | -5% |
|
|
2
Morgan Stanley
New York
| $166K | -$45.7K | -6,496 | -22% |
|
|
3
Wells Fargo
San Francisco,
California
| $45K | -$13.8K | -1,943 | -23% |
|
|
4
UBS Group
Zurich,
Switzerland
| $14K | +$10.3K | +1,392 | +278% |
|
5
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | – | – | – |
|